Epoch Q1 2026: Playing Defense, Adding AbbVie, Cutting Semis

Epoch Investment Partners runs a value-and-income style — the kind of strategy that prizes free-cash-flow generation and shareholder payouts over momentum — and its first-quarter 2026 filing shows that discipline turning defensive. The firm trimmed Applied Materials by 25%, Meta by 19%, and JPMorgan by 11% while raising its AbbVie stake by 11%, a clear lean away from semiconductors, social media, and banks and toward high-dividend pharma. It did so while its overall book continued to shrink, with reported value down 6.2% to $16.52 billion and the position count falling from 247 to 234.

That combination — cutting cyclical and richly valued names, adding a defensive dividend payer, and reducing the book overall — is the profile of a manager taking risk down. For a value-income strategy, that is not a contrarian bet so much as a return to type: when valuations stretch, this kind of manager rotates toward durable cash flows and away from the crowd.

Trimming semis, social media, and banks

The reductions concentrate in the names that led the market's recent run. Applied Materials, the semiconductor-equipment maker, was cut the hardest at 25% to $225.5 million, with Broadcom trimmed 7%. Meta Platforms was reduced 19% to $247.6 million, and banking giant JPMorgan was cut 11%.

These are not token trims. A 25% cut to a semiconductor-equipment name and a 19% cut to a megacap social-media platform are deliberate reductions in exactly the high-beta, high-multiple areas that a value-income manager would view as the most vulnerable if the market wobbles. The firm kept core positions in Nvidia, Apple, and Microsoft roughly flat — participating in big tech, but not adding to it.

Leaning into defensive income

The one clear add points the other way. AbbVie, the pharmaceutical company known for a robust dividend and a deep drug pipeline, was raised 11% to $327.6 million, making it the second-largest holding behind Nvidia.

That fits the strategy precisely: AbbVie is a high-free-cash-flow, high-payout business — the kind of defensive, income-generating name a value manager reaches for when it wants to reduce cyclicality without sitting in cash. Combined with the trims, the message is coherent: rotate from the parts of the market most exposed to a valuation reset toward steadier cash flows. The book remains highly diversified, with the top ten holdings accounting for only about 17% and a long tail making up the rest, including names like Alphabet and Cisco.

A shrinking book

Unlike many managers whose reported value has grown, Epoch's has been declining.

The reported 13F value has fallen steadily from about $21.9 billion in mid-2024 to $16.52 billion in the first quarter of 2026, with the position count drifting lower as well. A declining book paired with defensive trimming can reflect a mix of outflows, market action, and deliberate de-risking — but the direction is consistent. This is not a manager scaling up into the rally; it is one tightening a value-income portfolio as it shrinks.

What it signals

For investors who track institutional positioning, Epoch's first-quarter filing is a clean read on how a value-income discipline behaves late in a tech-led run: trim the semis, social media, and banks that have re-rated, hold the megacap core flat, and add to a defensive dividend payer like AbbVie. The actionable signal is the rotation's defensiveness — when an income-focused manager cuts its highest-beta names and reaches for cash-flow stability, it is positioning for a less forgiving market, whether or not one arrives.

FAQ

What did Epoch Investment Partners change in Q1 2026?
Epoch trimmed Applied Materials by 25%, Meta by 19%, JPMorgan by 11%, and Broadcom by 7%, while raising AbbVie by 11%. Reported 13F value fell 6.2% to $16.52 billion and the position count dropped from 247 to 234.

What is Epoch's largest holding?
Nvidia, at $369.8 million or 2.24% of the portfolio, held roughly flat, followed by AbbVie at $327.6 million after an 11% increase. The book is highly diversified, with the top ten at only about 17%.

Is Epoch turning defensive?
The filing suggests so. Cutting semiconductors, social media, and banks while adding a high-dividend pharma name and shrinking the book overall is the profile of a value-income manager reducing risk and reaching for cash-flow stability.

Why did Epoch's reported assets decline?
Reported 13F value fell from about $21.9 billion in mid-2024 to $16.52 billion, a steady drop that can reflect a mix of outflows, market action, and deliberate de-risking. The falling position count points in the same direction.